124 related articles for article (PubMed ID: 1847055)
1. A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34.
Fisher CW; Lau KS; Fisher CR; Wynn RM; Cox RP; Chuang DT
Biochem Biophys Res Commun; 1991 Jan; 174(2):804-9. PubMed ID: 1847055
[TBL] [Abstract][Full Text] [Related]
2. E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.
Chuang JL; Cox RP; Chuang DT
J Clin Invest; 1997 Aug; 100(3):736-44. PubMed ID: 9239422
[TBL] [Abstract][Full Text] [Related]
3. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations.
Fisher CW; Fisher CR; Chuang JL; Lau KS; Chuang DT; Cox RP
Am J Hum Genet; 1993 Feb; 52(2):414-24. PubMed ID: 8430702
[TBL] [Abstract][Full Text] [Related]
5. Four novel mutations identified in Norwegian patients result in intermittent maple syrup urine disease when combined with the R301C mutation.
Brodtkorb E; Strand J; Backe PH; Lund AM; Bjørås M; Rootwelt T; Rootwelt H; Woldseth B; Eide L
Mol Genet Metab; 2010 Aug; 100(4):324-32. PubMed ID: 20570198
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of mutations in maple syrup urine disease (MSUD): screening and identification of affected E1 alpha and E1 beta subunits of the branched-chain alpha-keto-acid dehydrogenase multienzyme complex.
Nobukuni Y; Mitsubuchi H; Hayashida Y; Ohta K; Indo Y; Ichiba Y; Endo F; Matsuda I
Biochim Biophys Acta; 1993 Nov; 1225(1):64-70. PubMed ID: 8161368
[TBL] [Abstract][Full Text] [Related]
8. Sequence of the E1 alpha subunit of branched-chain alpha-ketoacid dehydrogenase in two patients with thiamine-responsive maple syrup urine disease.
Zhang B; Wappner RS; Brandt IK; Harris RA; Crabb DW
Am J Hum Genet; 1990 Apr; 46(4):843-6. PubMed ID: 2316528
[TBL] [Abstract][Full Text] [Related]
9. Maple syrup urine disease caused by a partial deletion in the inner E2 core domain of the branched chain alpha-keto acid dehydrogenase complex due to aberrant splicing. A single base deletion at a 5'-splice donor site of an intron of the E2 gene disrupts the consensus sequence in this region.
Mitsubuchi H; Nobukuni Y; Akaboshi I; Indo Y; Endo F; Matsuda I
J Clin Invest; 1991 Apr; 87(4):1207-11. PubMed ID: 2010537
[TBL] [Abstract][Full Text] [Related]
10. Thiamin-responsive maple syrup urine disease in a patient antigenically missing dihydrolipoamide acyltransferase.
Ellerine NP; Herring WJ; Elsas LJ; McKean MC; Klein PD; Danner DJ
Biochem Med Metab Biol; 1993 Jun; 49(3):363-74. PubMed ID: 8347380
[TBL] [Abstract][Full Text] [Related]
11. Structural and biochemical basis for novel mutations in homozygous Israeli maple syrup urine disease patients: a proposed mechanism for the thiamin-responsive phenotype.
Chuang JL; Wynn RM; Moss CC; Song JL; Li J; Awad N; Mandel H; Chuang DT
J Biol Chem; 2004 Apr; 279(17):17792-800. PubMed ID: 14742428
[TBL] [Abstract][Full Text] [Related]
12. A novel deletion creating a new terminal exon of the dihydrolipoyl transacylase gene is a founder mutation of Filipino maple syrup urine disease.
Silao CL; Padilla CD; Matsuo M
Mol Genet Metab; 2004 Feb; 81(2):100-4. PubMed ID: 14741190
[TBL] [Abstract][Full Text] [Related]
13. Maple syrup urine disease: mutation analysis in Turkish patients.
Dursun A; Henneke M; Ozgül K; Gartner J; Coşkun T; Tokatli A; Kalkanoğlu HS; Demirkol M; Wendel U; Ozalp I
J Inherit Metab Dis; 2002 May; 25(2):89-97. PubMed ID: 12118532
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of the E1 beta subunit in the branched-chain alpha-keto acid dehydrogenase complex due to a single base substitution of the intron 5, resulting in two alternatively spliced mRNAs in a patient with maple syrup urine disease.
Hayashida Y; Mitsubuchi H; Indo Y; Ohta K; Endo F; Wada Y; Matsuda I
Biochim Biophys Acta; 1994 Feb; 1225(3):317-25. PubMed ID: 8312380
[TBL] [Abstract][Full Text] [Related]
15. Branched chain acyltransferase absence due to an Alu-based genomic deletion allele and an exon skipping allele in a compound heterozygote proband expressing maple syrup urine disease.
Herring WJ; McKean M; Dracopoli N; Danner DJ
Biochim Biophys Acta; 1992 Mar; 1138(3):236-42. PubMed ID: 1547285
[TBL] [Abstract][Full Text] [Related]
16. Lessons from genetic disorders of branched-chain amino acid metabolism.
Chuang DT; Chuang JL; Wynn RM
J Nutr; 2006 Jan; 136(1 Suppl):243S-9S. PubMed ID: 16365091
[TBL] [Abstract][Full Text] [Related]
17. Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease.
Friedrich T; Lambert AM; Masino MA; Downes GB
Dis Model Mech; 2012 Mar; 5(2):248-58. PubMed ID: 22046030
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
[TBL] [Abstract][Full Text] [Related]
19. Maple syrup urine disease. Complete defect of the E1 beta subunit of the branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease.
Nobukuni Y; Mitsubuchi H; Akaboshi I; Indo Y; Endo F; Yoshioka A; Matsuda I
J Clin Invest; 1991 May; 87(5):1862-6. PubMed ID: 2022752
[TBL] [Abstract][Full Text] [Related]
20. [A classic case with maple syrup urine disease caused by compound heterozygous mutations of BCKDHB gene].
Song D; Li W; Wei C; Wang W; Lyu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):699-702. PubMed ID: 30298499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
